Pandemic Darlings The pandemic economy, in original documents
Home Source documents Complaint (2022-03-02)

Complaint (2022-03-02)

Date
2022-03-02

Summary

Defendants' Response to Plaintiffs' Supplement, filed March 2, 2022 as Document 48 in America's Frontline Doctors, et al. v. United States of America, et al., Civil Action No. 2:21-cv-00702-CLM, in the U.S. District Court for the Northern District of Alabama. The response argues that the Excel file plaintiffs submitted is irrelevant to the case and that the Department of Defense has explained its data as the product of a glitch in the Defense Medical Epidemiology Database. It argues the supplement does not address any named plaintiff or any of the six counts in the Amended Complaint and cannot overcome the pending motion to dismiss or support a preliminary injunction. The defendants ask the Court to dismiss the Amended Complaint and deny the preliminary injunction motion. The filing is signed by Trial Attorney Isaac C. Belfer of the U.S. Department of Justice.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

        Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 1 of 8                         FILED
                                                                                     2022 Mar-02 PM 02:31
                                                                                     U.S. DISTRICT COURT
                                                                                         N.D. OF ALABAMA


                  IN THE UNITED STATES DISTRICT COURT
                FOR THE NORTHERN DISTRICT OF ALABAMA
                           SOUTHERN DIVISION


 AMERICA’S FRONTLINE
 DOCTORS, et al.,

             Plaintiffs,
                                                  CIVIL ACTION NO.
 v.                                               2:21-CV-702-CLM
                                                  OPPOSED
 UNITED STATES OF AMERICA, et
 al.,

             Defendants.


       DEFENDANTS’ RESPONSE TO PLAINTIFFS’ SUPPLEMENT
      The Court authorized Plaintiffs to submit a supplement, “the purpose of which

is to explain the relevance and significance of the Excel file” they provided to the

Court. ECF No. 46. Although Plaintiffs acknowledge their responsibility to establish
“the relevance of the Excel file,” ECF No. 47, at 1, they do not do so. Indeed, the

Excel file is irrelevant to this case. What’s more, the data it contains is incorrect. The

Court should disregard Plaintiffs’ supplement and dismiss this case.

      According to Plaintiffs, the Excel file shows that “prior to the commencement

of vaccination within the [Department of Defense (“DOD”)] with the mRNA

COVID-19 vaccines, the incidence of certain diseases and medical conditions

among DOD personnel was predictable and constant at a certain level over a number

of years from 2016 to 2020.” ECF No. 47, ¶ 6. But Plaintiffs assert that “after the

commencement of vaccination within the DOD with the mRNA COVID-19 vaccines
         Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 2 of 8




in 2021, the incidence of these diseases and medical conditions among DOD

personnel spiked dramatically.” Id.

       As Plaintiffs concede, DOD has already explained that the data in the Excel

file is incorrect and is the product of a “glitch” in the Defense Medical Epidemiology

Database (“DMED”) that “resulted in artificially low incidence numbers in the years

2016–2020.” ECF No. 47, ¶ 8.1 Plaintiffs reject this explanation, however, and

instead accuse the government of “alter[ing]” the data in DMED “to distort and hide
the true extent of the harm caused to the US Armed Forces by the mRNA vaccines.”

ECF No. 47, Ex. C. Plaintiffs’ unsupported speculation should not be countenanced

by the Court.

       More fundamentally, Plaintiffs’ supplement is improper because Plaintiffs

failed to heed the Court’s direction to explain the Excel file’s “relevance and

significance” to this case. ECF No. 46. Plaintiffs’ supplement does not reference any

of the eight named Plaintiffs, nor does it cite any of the six counts in the Amended

Complaint (ECF No. 32-1) or explain how the Excel file is relevant to them. The

Amended Complaint, moreover, does not mention DMED, does not name as parties
any members of the military, and does not assert any claims against the military.

Plaintiffs’ supplement is entirely untethered to the Amended Complaint.

       The supplement also makes no attempt to show the Excel file’s “relevance

and significance” (ECF No. 46) to Plaintiffs’ pending preliminary injunction motion


1
  See Reuters, Fact Check-DoD says data error caused spike in numbers of medical diagnoses in
their medical database for 2021, https://www.reuters.com/article/factcheck-militarydatabase-
error/fact-check-dod-says-data-error-caused-spike-in-numbers-of-medical-diagnoses-in-their-
medical-database-for-2021-idUSL1N2UY1S2 (Feb. 23, 2022).
                                             2
        Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 3 of 8




or Defendants’ pending motion to dismiss. Nor could Plaintiffs have met that burden

had they tried. The supplement cannot overcome Defendants’ arguments that the

Court lacks subject matter jurisdiction because (1) no plaintiff possesses standing or

ripe claims; (2) the challenged actions taken under 21 U.S.C. § 360bbb-3 are not

reviewable under the Administrative Procedure Act (“APA”); (3) no jurisdiction

exists under the mandamus statute or the Declaratory Judgment Act; and (4) the Civil

Service Reform Act precludes jurisdiction over any challenge by Plaintiffs Nelson

and Leahy to potential adverse employment action reviewable under that statute.

      The supplement also cannot rebut Defendants’ arguments that the Amended

Complaint fails to state a plausible claim for relief because (1) Counts I, III, and IV
do not purport to challenge the Emergency Declaration and Emergency Use

Authorizations in light of Defendants’ contemporaneous explanations and the

existing administrative record, as required for an APA claim; (2) Executive Orders
14042 and 14043 (collectively, the “Executive Orders”) are not reviewable under

the APA because the President is not an “agency”; (3) the Executive Orders do not

deprive Plaintiffs of substantive due process; and (4) the Executive Orders are within

the President’s statutory authority. Moreover, the new allegations in Plaintiffs’

supplement could not defeat Defendants’ motion to dismiss because they are outside

“the four corners of the [amended] complaint.” St. George v. Pinellas Cty., 285 F.3d

1334, 1337 (11th Cir. 2002). And although “[a]ll counts in the amended complaint

are predicated on” the APA, ECF No. 37, at 41, Plaintiffs’ supplement cannot

support an APA claim because it presents new evidence that is outside “the existing
administrative record,” Dep’t of Com. v. New York, 139 S. Ct. 2551, 2573 (2019),
                                          3
        Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 4 of 8




and it does not claim that its allegations were ever presented to Defendants, Mahon

v. U.S. Dep’t of Agric., 485 F.3d 1247, 1254–55 (11th Cir. 2007); see 21 C.F.R.

§§ 10.25, 10.30, 10.45.

      Finally, Plaintiffs’ supplement cannot support their preliminary injunction

motion. It cannot show a likelihood of success on the merits because it cannot

overcome Defendants’ showing that the Amended Complaint should be dismissed

for lack of subject matter jurisdiction and failure to state a claim. See Klay v. United

Healthgroup, Inc., 376 F.3d 1092, 1097–98 (11th Cir. 2004) (“For a traditional

injunction to be even theoretically available, a plaintiff must be able to articulate a

basis for relief that would withstand scrutiny under Fed. R. Civ. P. 12(b)(6).”).
Moreover, the supplement cannot support preliminary relief because it addresses “a

matter lying wholly outside the issues in the suit.” Kaimowitz v. Orlando, 122 F.3d

41, 43 (11th Cir. 1997), opinion amended on reh’g, 131 F.3d 950 (11th Cir. 1997).
      Silent about any named Plaintiff, the supplement also cannot show that any

Plaintiff would suffer irreparable harm “before [this] case can be resolved on its

merits.” Wreal, LLC v. Amazon.com, Inc., 840 F.3d 1244, 1248 (11th Cir. 2016). As

Defendants explained in their reply brief, there is no imminent risk that the Executive

Orders will force Plaintiffs Makowski, Nelson, and Leahy to receive any COVID-

19 vaccine, let alone one authorized under an Emergency Use Authorization.

Makowski’s medical accommodation request was granted; Nelson’s and Leahy’s

religious accommodation requests remain pending; and Nelson’s and Leahy’s

employer has paused the processing of their religious accommodation requests in
compliance with the nationwide preliminary injunction enjoining enforcement of
                                           4
         Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 5 of 8




Executive Order 14043 issued in Feds for Med. Freedom v. Biden, No. 3:21-CV-

356, 2022 WL 188329, at *7–8 (S.D. Tex. Jan. 21, 2022), appeal filed, No. 22-40043

(5th Cir. Jan. 26, 2022).2 ECF No. 44, at 7–8 & n.5.

       Instead of attempting to show a connection to this case, Plaintiffs’ supplement
focuses on wholly unrelated conduct: the Department of Defense’s maintenance of

DMED. Federal courts, however, “do not possess a roving commission,” and they

do not “exercise general legal oversight of the Legislative and Executive Branches.”

TransUnion LLC v. Ramirez, 141 S. Ct. 2190, 2203 (2021). Plaintiffs’ counsel may

not use this lawsuit to pursue matters unrelated to the claims at issue in this case.

       In sum, the Court should disregard Plaintiffs’ supplement because Plaintiffs

have failed to show that it has any “relevance [or] significance” to this case. ECF

No. 46. For the reasons stated in Defendants’ briefs, see ECF Nos. 42, 44, the Court

should dismiss Plaintiffs’ Amended Complaint pursuant to Federal Rule of Civil
Procedure 12(b)(1) and (b)(6) and deny Plaintiffs’ motion for a preliminary

injunction.


Dated: March 2, 2022                          Respectfully submitted,

OF COUNSEL:                                   BRIAN M. BOYNTON
                                              Principal Deputy Assistant Attorney
DANIEL BARRY                                  General
Acting General Counsel
2
  In addition, the Southern District of Georgia has issued a nationwide preliminary injunction
enjoining enforcement of Executive Order 14042. Georgia v. Biden, No. 1:21-CV-163, 2021 WL
5779939, at *12 (S.D. Ga. Dec. 7, 2021), appeal filed, No. 21-14269 (11th Cir. Dec. 10, 2021);
see Feds for Med. Freedom, 2022 WL 188329, at *1 (denying motion to preliminarily enjoin
enforcement of Executive Order 14042 because that Executive Order “is already the subject of a
nationwide injunction” that “protects the plaintiffs from imminent harm”).
                                              5
       Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 6 of 8




U.S. Department of Health and Human   ARUN G. RAO
Services                              Deputy Assistant Attorney General

WENDY VICENTE                         GUSTAV W. EYLER
Acting Deputy Chief Counsel,          Director
Litigation
                                      HILARY K. PERKINS
JAMES ALLRED                          Assistant Director
Associate Chief Counsel
Office of the Chief Counsel           /s/_ Isaac C. Belfer _____
U.S. Food and Drug Administration     ISAAC C. BELFER
10903 New Hampshire Avenue            Trial Attorney
White Oak 31, Rm 4564                 JAMES W. HARLOW
Silver Spring, MD 20993-0002          Senior Trial Attorney
                                      Consumer Protection Branch
                                      Civil Division
                                      U.S. Department of Justice
                                      P.O. Box 386
                                      Washington, DC 20044-0386
                                      Tel: (202) 305-7134 (Belfer)
                                      Tel: (202) 514-6786 (Harlow)
                                      Fax: (202) 514-8742
                                      Email: Isaac.C.Belfer@usdoj.gov
                                      Email: James.W.Harlow@usdoj.gov

                                      PRIM F. ESCALONA
                                      United States Attorney

                                      DON B. LONG, III
                                      Assistant United States Attorney
                                      United States Attorney’s Office
                                      Northern District of Alabama
                                      1801 Fourth Avenue North
                                      Birmingham, Alabama 35203
                                      Tel: (205) 244-2106
                                      Fax: (204) 244-2171
                                      Email: Don.Long2@usdoj.Gov

                                      Counsel for Defendants the United
                                      States of America; Joseph R. Biden, Jr.,
                                      6
Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 7 of 8




                              President of the United States; Xavier
                              Becerra, Secretary of Health and
                              Human Services; Dr. Anthony Fauci,
                              Director of the National Institute of
                              Allergy and Infectious Diseases; Dr.
                              Janet Woodcock, Acting Commissioner
                              of Food and Drugs; the U.S.
                              Department of Health and Human
                              Services; the Food and Drug
                              Administration; the Centers for Disease
                              Control and Prevention; the National
                              Institutes of Health; and the National
                              Institute of Allergy and Infectious
                              Diseases




                             7
        Case 2:21-cv-00702-CLM Document 48 Filed 03/02/22 Page 8 of 8




                          CERTIFICATE OF SERVICE
      I hereby certify that on March 2, 2022, I electronically filed the foregoing with

the Clerk of the Court using the CM/ECF system, which will send notification of
such filing to counsel of record.


                                              /s/_ Isaac C. Belfer _____
                                              ISAAC C. BELFER
                                              Trial Attorney




                                          8


File and source

File
gov.uscourts.alnd.177186.48.0.pdf
Size
169,635 bytes
SHA-256
814bceaa699984057ee9b8b60b721a5c44b4cfe3f8c419e65038958f720fc049
Our copy
gov.uscourts.alnd.177186.48.0.pdf
Original
archive.org
Back to top